SHELBY DAVIS: Open Payments
NPI 1073107587 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253 in 12 payments from 7 companies in 2025. Trend: 2023 $245 · 2024 $463 · 2025 $253
Food & beverage: $253
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $88 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $54 |
| ABIOMED | 1 | $41 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Kestra Medical Technology Services, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: LEQVIO, LifeVest, NEXLETOL, Assure WCD, FARXIGA.
Industry payments across FL — which companies pay providers there.
